These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26544651)

  • 21. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
    Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
    Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
    Bezwada P; Shaikh A; Misra D
    J Womens Health (Larchmt); 2017 Dec; 26(12):1319-1325. PubMed ID: 28622476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
    Canonico M; Plu-Bureau G; Lowe GD; Scarabin PY
    BMJ; 2008 May; 336(7655):1227-31. PubMed ID: 18495631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M
    Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.
    Ohira T; Folsom AR; Cushman M; White RH; Hannan PJ; Rosamond WD; Heckbert SR
    Br J Haematol; 2010 May; 149(4):606-12. PubMed ID: 20230397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women.
    Canonico M; Bouaziz E; Carcaillon L; Verstuyft C; Guiochon-Mantel A; Becquemont L; Scarabin PY;
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3082-7. PubMed ID: 18628519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT.
    L'Hermite M
    Climacteric; 2013 Aug; 16 Suppl 1():44-53. PubMed ID: 23848491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
    Simon JA
    Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies.
    Xiong A; Hu Z; Zhou S; Qiang Y; Song Z; Chen H; Xiang Q; Zhang Y; Cao Y; Cui H; Luo J; Wang Y; Yang Y; Cui B; Li M; Shuai S
    Rheumatology (Oxford); 2022 Jul; 61(7):2728-2739. PubMed ID: 34791063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens.
    Smith NL; Blondon M; Wiggins KL; Harrington LB; van Hylckama Vlieg A; Floyd JS; Hwang M; Bis JC; McKnight B; Rice KM; Lumley T; Rosendaal FR; Heckbert SR; Psaty BM
    JAMA Intern Med; 2014 Jan; 174(1):25-31. PubMed ID: 24081194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Menopause and risk of thromboembolic events. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
    Hugon-Rodin J; Perol S; Plu-Bureau G
    Gynecol Obstet Fertil Senol; 2021 May; 49(5):455-461. PubMed ID: 33757918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence.
    Kunutsor SK; Seidu S; Khunti K
    Ann Med; 2018 Sep; 50(6):529-537. PubMed ID: 30001640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M; Scarabin PY
    Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.